摘要
个体对药物吸收、转运、代谢、消除的不同是基于药物基因组学的多态性。在心血管相关药物基因组学中,有研究表明,其不仅影响药物的有效性、安全性,部分基因还与脑卒中进展、预后相关。本文对目前常见的心血管药物基因对脑卒中患者的进展、预后作一综述,为临床用药指导及判断患者预后提供部分思路。
Individual differences in drug absorption,transportation,metabolism and elimination are based on polymorphism of pharmacogenomics.In the genomics of cardiovascular related drugs,some studies have shown that they not only affect the effectiveness and safety of drugs,some genes are related to the progress and prognosis of stroke.This article reviews the progress and prognosis of common cardiovascular drug genes in stroke patients,and provides some ideas for clinical medication guidance and prognosis judgment.
作者
邹璐
姚黎清
ZOU Lu;YAO Li-qing(Department of Rehabilitation Medicine,the Second Affiliated Hospital of Kunming Medical University,Kunming 650000,Yunnan,China)
出处
《医学信息》
2022年第7期15-18,共4页
Journal of Medical Information
基金
国家自然科学基金地区科学基金项目(编号:81760414)
云南省科技重大专项项目(编号:2018ZF016)
云南省康复临床医学中心(编号:zx2019-04-02)。